Results 181 to 190 of about 22,830 (226)

ALK-negative anaplastic large cell lymphoma in pediatric and adolescent patients: a mini-review. [PDF]

Front Oncol
Devine KJ, Stokke J, Lim MS, Schwartz LF.   +3 more
europepmc   +1 more source

Immunohistochemistry (IHC) Versus Genomic Profiling in Cancer: Roles in Precision Medicine. [PDF]

Cureus
Elshami YM, Abukhelaif A, Elrheima OA, Ishaq AG, Ali NA.   +4 more
europepmc   +1 more source

Next generation sequencing guided treatment of <i>ALK</i> tyrosine kinase inhibitor induced long survival in lung squamous cell carcinoma harboring <i>ROS1</i> gene fusions: a case report and literature review. [PDF]

Front Med (Lausanne)
Liu M, Li F, Mu N, Kang N, Wu S, Xu Y, Wang X, Lü H, Ma C.   +8 more
europepmc   +1 more source

Gene fusions in melanocytic lesions: an updated comprehensive review. [PDF]

J Pathol Transl Med
Lenskaya V, Erikson L, Prieto VG, Cho WC.   +3 more
europepmc   +1 more source

Real-World Treatment Patterns and Clinical Outcomes After First-Line Therapy in Patients with KRAS G12C-Mutant Advanced Non-Small-Cell Lung Cancer in the United States. [PDF]

Cancers (Basel)
Sheffield KM, Puri T, Thoele K, Karu H, Mansharamani A, Uprety D.   +5 more
europepmc   +1 more source

Real-World Treatment Patterns and Survival in Patients with <i>ROS1</i>-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe. [PDF]

Curr Oncol
Cheung WY, Lee A, Bote de Cabo H, Burdenski K, Christopoulos P, Pinto-Correia B, Deshayes S, Girard N, Hindocha P, Madden Á, Mella M, Moreira J, Rizzi S, Abreu DR, Soares M, Thomas J, Han M, Calvet CY, Emanuel G, Glassberg MB, Jacobs H, Rault C, Yuan Y, Chouaid C.   +23 more
europepmc   +1 more source

Harmonizing biomarker testing in NSCLC: The critical role of cytopathology in delivering comprehensive biomarker testing for patients with NSCLC. [PDF]

Cancer Cytopathol
Roy-Chowdhuri S, Mani H.
europepmc   +1 more source

Heterogeneous efficacy and predictors of response to immunotherapy in driver-mutant advanced NSCLC: a focus on EGFR and KRAS subtypes. [PDF]

Transl Lung Cancer Res
Zhu Y, Wang S, Wang C, Sun D, Wang D, Ma F, Wu S.   +6 more
europepmc   +1 more source

<i>ROS1</i>-positive non-small cell lung cancer: from genomics to treatment decisions. [PDF]

Front Oncol
Wespiser M, Gille R, Pérol M.
europepmc   +1 more source